CYDY
Price:
$0.115
Market Cap:
$140.28M
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (COVID-19). It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.[Read more]
Industry
Biotechnology
IPO Date
2006-12-13
Stock Exchange
PNK
Ticker
CYDY
According to CytoDyn Inc.’s latest financial reports and current stock price. The company's current ROE is 17.48%. This represents a change of 588.33% compared to the average of 2.54% of the last 4 quarters.
The mean historical ROE of CytoDyn Inc. over the last ten years is 1.03%. The current 17.48% ROE has changed -98.30% with respect to the historical average. Over the past ten years (40 quarters), CYDY's ROE was at its highest in in the May 2020 quarter at 3.53%. The ROE was at its lowest in in the August 2020 quarter at -1304.05%.
Average
1.03%
Median
336.77%
Minimum
-251.86%
Maximum
5.72%
Discovering the peaks and valleys of CytoDyn Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 806.84%
Maximum Annual ROE = 5.72%
Minimum Annual Increase = -1027.21%
Minimum Annual ROE = -251.86%
Year | ROE | Change |
---|---|---|
2024 | 42.69% | -41.44% |
2023 | 72.90% | -76.12% |
2022 | 305.26% | -63.13% |
2021 | 827.95% | -85.52% |
2020 | 5.72% | 806.84% |
2019 | 630.32% | 71.15% |
2018 | 368.28% | -84.23% |
2017 | 2.34% | -1027.21% |
2016 | -251.86% | -203.87% |
2015 | 242.48% | -176.50% |
The current ROE of CytoDyn Inc. (CYDY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
140.28%
5-year avg
1.39%
10-year avg
1.03%
CytoDyn Inc.’s ROE is greater than Intercept Pharmaceuticals, Inc. (-12.41%), greater than Madrigal Pharmaceuticals, Inc. (-71.78%), greater than scPharmaceuticals Inc. (-314.97%), greater than Akero Therapeutics, Inc. (-32.52%), greater than Aravive, Inc. (-433.14%), greater than Cardiff Oncology, Inc. (-73.97%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than PDS Biotechnology Corporation (-139.57%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%),
Company | ROE | Market cap |
---|---|---|
-12.41% | $794.69M | |
-71.78% | $7.58B | |
-314.97% | $167.63M | |
-32.52% | $2.28B | |
-433.14% | $2.95M | |
-73.97% | $125.28M | |
664.92% | $38.12M | |
2.18% | $941.00 | |
-139.57% | $78.19M | |
-173.56% | $100.08K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytoDyn Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CytoDyn Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CytoDyn Inc.'s ROE?
How is the ROE calculated for CytoDyn Inc. (CYDY)?
What is the highest ROE for CytoDyn Inc. (CYDY)?
What is the 3-year average ROE for CytoDyn Inc. (CYDY)?
What is the 5-year average ROE for CytoDyn Inc. (CYDY)?
How does the current ROE for CytoDyn Inc. (CYDY) compare to its historical average?